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Plasma amino acids in children and adolescents on hemodialysis.
Fasting plasma amino acid concentrations were measured in 16
children on regular hemodialysis for renal failure. Reductions
compared to normal were found in valine, leucine, isoleucine,
lysine, histidine, tyrosine, and serine; and increases were found in
glycine, citrulline, proline, and 1- and 3-methylhistidine. Acute
reductions in amino acid concentrations occurred in response to
i.v. glucose, similar to those reported in normal adults, but plasma
alanine, which was raised only in those with poor glucose toler-
ance, fell to normal and did not vary in those with normal glucose
tolerance. No correlations were found with growth, but the plasma
glycine concentration was highest in those patients with poorest
energy intakes. Plasma alanine concentrations correlated with
raised triglyceride concentrations. It is suggested that many of the
abnormalities are due to the excessive utilization of protein for
energy because of impaired availability of conventional energy
sources in uremia.
Acides aminés du plasma chez lea enfants et adolescents en hémo-
clialyse. Les concentrations des acides aminés du plasma ont été
mesurées a jeun chez 16 enfants en hémodialyse iterative pour
insuffisance rénale. Par comparaison avec des sujets normaux, des
diminutions ont etc constatees pour valine, leucine, isoleucine,
lysine, histidine, tyrosine et serine et des augmentations pour gly-
ine, citrulline, proline et I- et 3—méthylhistidine. Des dimunutions
aigues des concentrations d'acides aminés ont été observées en
response a l'administration intraveineuse de glucose, semblable a
celles rapportees chez les adultes normaux, a l'exception de
l'alanine dont Ia concentration n' a pas etC modifiCe chez les sujets
ayant une tolerance au glucose normale et a été abaissée a des
valeurs normales, a partir d'une valeur Clevée, chez les sujets ayant
une tolerance au glucose diminuCe. Aucune correlation n' a etC
observée avec Ia croissance mais La concentration plasmatique de
glycine est Ia plus ClevCe chez les malades dont l'apport CnergCtique
est Ic plus faible. Les concentrations plas matiques d' alanine sont
corrClCes avec l'augmentation de Ia concentration des triglycerides.
LI est suggCrC que beaucoup de ces anomalies sont liCes a
l'utilisation excessive des proteines comme source d'Cnergie en
raison de Ia diminution des sources d'Cnergie conventionnelles an
ours de l'urémie.
Plasma amino acid concentrations are abnormal in
iremic adults even after treatment by hemodialysis
1, 2, 3]. The concentrations of some essential amino
tcids are frequently reduced and those of nones-
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sential amino acids are normal or increased. Certain
changes, such as the reduced ratio of tyrosine to
phenylalanine [4], decreased valine/glycine ratio [5],
and increased citrulline concentrations [6] are charac-
teristic, while others such as alterations of histidine
and phenylalanine concentrations vary from study to
study. Some of these changes are also seen in energy-
protein malnutrition and it has been difficult to dis-
tinguish whether changes in uremia reflect a specific
metabolic disturbance, or are secondary to malnutri-
tion.
There is little published information on the
changes in children. We have measured plasma
amino acid concentrations in a group of children on
regular dialysis and related them to growth, nutri-
tion, and other biochemical parameters.
Methods
Subjects. Sixteen children, 9 boys and 7 girls with a
mean age of 14 years (11 to 17 years) who had been
on regular hemodialysis in the home for more than
six months (seven months to six and one-half years),
were studied (Table 1). None had any systemic dis-
ease and all were stable at the time of investigation.
They dialyzed for ten hours overnight on three nights
of each week, 13 using Meltec Multipoint dialysers,
two using Watson-Marlow Kiil type dialyzers and
one using a Travenol Ultra-Flo dialyzer. The dialy-
sates had a glucose concentration of 200 mg/tOO ml.
Normal meals were eaten and dietary restrictions
were confined to sodium and potassium, where neces-
sary, and fluid intake was limited to approximately
300 ml per day. Each child also took a variable
amount of a highly concentrated energy mixture
based on double cream and a glucose polymer (Cab-
reen®, Mimer Scientific and Medical Research Com-
pany, Liverpool, England). Control values were ob-
tained from children having venepuncture for other
reasons while inpatients for minor surgery. None had
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Table I. Clinical data of children on hemodialysis
Patient Age, Bone Height,
Height centile Height velocity, cm/yr .Duration on
dialysis,chron. bone expected for
No. Renal disease yrs age cm age age actual bone age yr
I Reflux nephropathy 17.8 15.0 150.1 <3rd 3rd-lOth 1.0 1.2 3.5
2 Reflux nephropathy 12.4 13.5 152.3 75th 25th-SOth 6.5 4.5 1.0
3 Reflux nephropathy 12.0 8.0 132.1 <3rd 75th-90th 4.2 5.5 5.5
4 Reflux nephropathy 12.8 8.5 127.4 <3rd 50th 3.4 5.4 3.0
5 Reflux nephropathy 11.3 11.0 128.1 3rd 3rd 4.1 6.1 0.58
6 Focalglomeruloscierosis 16.0 14.0 143.6 <3rd <3rd 1.1 7.3 2.0
7 Focal glomerulosclerosis 12.3 12.5 141.4 25th 25th 1.9 5.5 1.0
8 Focal glomerulosclerosis 14.1 8.0 139.9 <3rd >97th 2.6 5.5 3.0
9 Chronieglomerulonephritis 15.0 15.0 160.1 50th 50th 5.8 5.8 1.5
10 Chronicglomerulonephritis 14.6 10.0 139.1 <3rd SOth-75th 6.2 5.1 6.5
II Juvenile nephronophthisis 12.8 12.0 142.1 10th 25th 1.6 5.0 2.5
12 Juvenilenephronophthisis 14.9 15.0 140.1 <3rd <3rd 2.6 1.1 0.75
13 Singledysplastickidney 16.0 — 148.0 <3rd — — — 1.5
14 Obstructiveuropathy 14.8 10.0 136.6 <3rd 50th — — 1.5
15 Cystinosis 14.5 11.5 127.4 <3rd <3rd 5.5 4.9 1.0
16 Cystinosis 11.7 11.0 129.3 <3rd 3rd 2.3 5.0 2.0
renal disease or systemic disturbance, and no dietary
information was available.
The study was approved by the Medical School
Ethical Committee and consent obtained in writing
from the children's parents after full explanation to
both parents and children.
Methods. After an overnight fast of at least 14 hr
duration, 24 to 48 hr after finishing a dialysis, blood
samples were collected without stasis in the resting
state from the venous side of arteriovenous fistulae
into heparinized tubes. Thirteen of the children also
had i.v. glucose tolerance tests (IVGTT = 0.5 g of
50% glucose per kg of body weight) and blood sam-
ples for amino acid analysis were obtained after fast-
ing and at one hour after glucose injection. The
samples were separated promptly, deproteinized with
1% picric acid, to which norleucine had been added as
internal standard and stored at —20° C prior to analy-
sis. Amino acids were measured by ion-exchange
chromatography on an automatic amino acid ana-
lyzer (LKB 3201). A three sodium buffer step system
was used with a constant operating temperature of
60°C. Aliquots of plasma were also analyzed for
triglycerides by a semiautomated method [7], for cho-
lesterol by the automated method of Levine and Zak
[8] and for nonesterified fatty acids (NEFA) by a
semiautomated fluorimetric method [9]. Blood glu-
cose was measured by autoanalyzer (ferricyanide
method, Technicon), plasma albumin by autoanaly-
zer (bromocresol dye-binding method, Technicon),
plasma urea by autoanalyzer (diacetylmonoxine reac-
tion), plasma creatinine by autoanalyzer (Technicon,
method 1 lb), plasma transferrin by single radial im-
munodiffusion, and plasma insulin by double an-
tibody radioimmunoassay [10].
Linear growth was measured according to the
method of Tanner, Whitehouse, and Takaishi [11],
and bone age was assessed by independent observers
using the method of Greulich and Pyle [12].
Food intakes were assessed by three-day prospec-
tive weighed recordings done at home, usually on
Friday, Saturday, and Sunday and including one
dialysis day (Table 2). These are performed regularly
and the intakes used for this study were all recorded
within three weeks of the blood samples being ob-
tained. The dietary intakes were expressed as a per-
centage of the recommended dietary allowance [13],
according to the height age of the child.
Statistical methods. Student's t test was used to
compare amino acid concentrations in patients and
controls. The relationships between amino acids and
growth, nutrition, and other biochemical parameters
were analyzed by least squares linear regression. The
significance of changes in amino acid concentrations
in response to glucose was assessed by paired t tests.
Results
The means and standard deviations of plasma am-
ino acid concentrations in patients and controls are
shown in Table 3. Values are not shown for threon-
me, because of its poor separation from glutamine;
tryptophan, because of its appreciable reduction by
the use of picric acid as a deproteinizing agent [14];
and glutamine because of its cyclization to pyrroli-
dine carboxylic acid known to occur at the column
temperature used [15].
There were significant reductions in concentrations
of valine, leucine, isoleucine, lysine, tyrosine, serine,
and histidine. Glycine, citrulline, proline, and 1- and
3-methyihistidine were significantly elevated, while
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Table 2. Diets of children on dialysis
Energy Protein Carbohydrate Fat
Patient No. kjoules/day %RDAa g/day %RDAa g/day %RDAa g/day %RDM
9520 99 60 103 303 101 97 114
2 12127 126 132 228 244 82 156 184
3 14102 134 84 133 378 109 171 184
4 10964 125 56 106 321 118 128 162
5 15911 181 118 183 396 132 198 251
6 11698 112 79 125 327 101 135 145
7 10983 105 77 122 246 102 150 161
8 12493 130 64 110 389 130 215 253
9 12001 102 66 88 265 80 173 166
10 4886 47 46 73 136 42 51 55
11 — — — — — — — —
12 10306 107 68 117 297 109 116 136
13 18684 159 128 70 389 107 268 258
14 6415 61 46 73 183 56 71 76
15 9175 104 55 104 237 87 116 147
16 8010 91 18 34 302 Ill 76 96
a RDA = Recommended Daily Allowance.
the remainderwere within normal limits. Alanine was at the 5% level. A direct linear relationship was
at the upper limit of normal. The ratio of tyrosine to shown between the plasma citrulline concentration
phenylalanine was consistently reduced, mainly due and energy and protein intake (Table 4). Other amino
to the reduction in tyrosine concentration. The va- acid concentrations did not correlate at the 5% level
line/glycine ratio was also low because of the reduced with albumin and there was no correlation between
valine concentration and raised glycine concentra- amino acid concentrations and transferrin and hemo-
tion. globin concentrations. The plasma albumin concen-
Effect of diet and nutritional state. There was an trations were all within the normal range (3.6 to 5.3
inverse linear relationship between glycine concentra- g/lOO ml) and did not correlate with diet.
tion and fat and energy intakes (Table 4). The Va- Amino acids and growth. Each amino acid was ana-
line/glycine ratio showed a similar, though not as lyzed in relation to the degree of growth failure,
close a relationship, and the plasma valine concentra- growth velocity, and bone maturity and no signifi-
tion was not influenced by diet at all. However, there cant associations were found.
was a direct linear relationship between the plasma Amino acids and lipids. Full results of plasma lipid
valine concentration and plasma albumin, significant determinations will be published elsewhere. Plasma
Table 3. Plasma amino acid concentrations in patients and controls
Patients Controls
Mean Mean
Amino acid No. nmo//ml st No. n,nol/mI SD P
Valine 16 145 29 8 207 27 <0.001
Leucine 16 69 13 8 102 16 <0.001
Isoleucine 16 42 13 8 52 7 <0.05
Lysine 15 155 23 8 181 26 <0.05
Methionine 14 14 4 7 17 2 NS
Phenylalanine 16 39 9 8 40 5 NS
Histidine 16 70 11 8 86 19 <0.05
Alanine 16 380 150 8 275 49 NS
Glycine 16 405 113 8 224 30 <0.001
Citrulline 16 89 22 8 78 7 <0.001
Serine 15 83 21 7 163 27 <0.001
Tyrosine 16 23 6 8 40 8 <0.001
Cystine 15 56 15 2 35 3 NS
Ornithine 15 62 15 8 59 18 NS
Arginine 13 74 21 8 70 10 NS
Proline 15 231 105 7 133 37 <0.05
Tyrosine/phenylalanine 16 0.61 0.12 8 0.99 0.17 <0.001
Valine/glycine 16 0.39 0.14 8 0.93 0.19 <0.001
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Table 4. Relationship between diet and plasma amino acid concentrations
Aminoacid
Protein Fat Carbohydrate Energy














































triglyceride concentrations were significantly raised
and correlated with plasma alanine (r = +0.55; N =
16; P < 0.05). Plasma cholesterol concentrations
were also significantly raised and correlated inversely
with plasma proline (r = —0.57; N = 15; P < 0.05)
and plasma proline concentrations correlated directly
with plasma nonesterified fatty acids (NEFA) (r =
+0.61; N = 15; P < 0.05). The NEFA tended to be
low, but not significantly so.
The effect of glucose. There was a significant mean
reduction in the concentrations of valine, leucine and
isoleucinc, tyrosine, alanine, lysine, ornithine and Se-
rifle 60 mm after glucose injection (Table 5). Other
amino acids also fell in concentration, but not signifi-
cantly. These changes did not correlate with the peak,
or the 60 mm plasma insulin concentrations.
The concentration of alanine 60 mm after glucose
injection was expressed as a percentage of the fasting
level and compared to the glucose disappearance rate
(K) during the IVGTT. There was a close linear rela-
tionship between the percentage reduction and the K
values (Fig. 1). The fasting concentrations of alanine
correlated inversely with the K values for glucose
Table 5. Plasma amino acid concentration during fasting and
60 mm after glucose infusion
(r =
—0.62; N = 13; P < 0.05); thus, the worse the
glucose tolerance, the higher the fasting concentra-
tion of alanine and the greater its fall after glucose.
Those with better glucose tolerance had normal
plasma alanine concentrations, which showed little or
no change when glucose was injected. These findings
did not apply to any of the other amino acids.
A mino acids and residual renal mass and uremia.
Two patients were anephric and analysis of their
results showed no significant difference in com-
parison to the remainder. No plasma amino acid
concentration correlated with that for creatinine but
the plasma urea concentration correlated inversely
both with the plasma glycine (r =
—0.6031; P < 0.05)








During fastingNo. of glucose infusion
Amino acid patients mean 5EM mean SEM P
Valine 13 164 10 146 9 <0.001
Leucine 13 73 5 62 4 <0.001
Isoleucine 13 44 3 37 3 <0.01
Lysine Ii 159 10 148 9 <0.05
Methionine 9 11 2 9 1 NS
Phenylalanine 13 38 2 38 2 NS
Histidine 13 69 5 69 4 NS
Arginine 13 75 5 76 5 NS
Glycine 12 392 30 385 28 NS
Alanine 13 337 39 298 27 <0.05
Serine 13 84 6 75 4 <0.05
Cystine 11 60 6 58 6 NS
Ornithine 11 60 5 53 3 <0.05
Tyrosine 13 21 I 17 I <0.01
Citrulline 13 92 4 84 4 NS
r = + 0.644
y = 22x + 64
50 I I I I I I
0.4 0.8 1.2 1.6 2.0
Glucose disappearance rate (K) during iv.
glucose tolerance test
Fig. 1. Relationship between the percentage of reduction in plasma
alanine concentration 60 minutes after glucose injection and the K
values for glucose during i.v. glucose tolerance tests.
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Discussion
These patients were at the upper age range of child-
hood for practical reasons; five were pubertal, four
were in early puberty, and the remainder were pre-
pubertal. Most had a retarded bone age (Table 1).
While age does influence plasma amino acid concen-
trations, there is no evidence that significant changes
occur over the age range we studied, and the controls
were of a comparable age.
Comparison with similar reports on adults on
hemodialysis shows how much interstudy variation
exists. Direct quantitative comparisons are restricted
by differences in methodology, such as sample prepa-
ration and analytical procedures. In most reports
there is little information on dietary intakes and it is
likely that considerable variation exists. The effect of
heterogeneity of body composition is not known, nor
are the effects of residual renal mass. Our data do
not show significant differences between anephric
patients and others but are too scanty in this respect
to be helpful.
Reductions in the concentrations of the branched-
chain amino acids—valine, leucine and isoleucine—
and tyrosine and lysine are the changes most consist-
ently found. McGale, Pickford, and Aber [17] have
found glycine to be increased as we have, whereas
Held et al [3] have reported a reduction not only in
glycine, but also in alanine and phenylalanine.
Phenylalanine has been most frequently reported to
be normal in concentration in uremic patients, both
on and off dialysis [1]. Histidine concentrations may
be normal [2], or reduced [1], while 1- and 3-meth-
ylhistidine concentrations are typically increased [1,
3, 17]. The ratio of essential to nonessential amino
acids is reduced in uremia, but we have not analyzed
this, because Kopple and Swendseid [5] have shown
that this ratio is a function of protein intake, rather
than uremia. In addition we have excluded some
amino acids from analysis for technical reasons and
this would affect the ratio. We suggest that the differ-
ences found from study to study are more influenced
by nutrition (and perhaps body composition),
whereas the similarities could be the consequence of
uremia, with malnutrition playing a less important
role.
Both plasma glycine and alanine concentrations
showed a significant inverse relationship with the
plasma urea, but no amino acid correlated with the
plasma creatinine concentration. The efficacy of
dialysis is difficult to measure. All the children were
dialyzed similarly for 30 hr each week with mem-
branes of appropriate size to body surface area and
so the plasma creatinine and urea are probably in-
fluenced more by the patients' muscle mass and pro-
tein intake, respectively. Notwithstanding this, it is
possible that the changes in these two amino acids
were independent of the efficacy of the dialysis pro-
cedure (as evidenced by the plasma creatinine), but
that they may have been influenced by other factors
which could elevate the urea, such as high protein
intake or endogenous protein catabolism. While nei-
ther amino acid correlated significantly with the pro-
tein intake, Table 4 shows that the plasma glycine
concentration tended to vary inversely with the pro-
tein intake.
In the present study overt clinical signs of malnu-
trition were not present, but growth retardation and
delayed bone maturation frequently were. Dietary
intakes recorded in our children and expressed ac-
cording to actual body weight or height age seem
adequate, but in the face of chronic malnutrition
there may be greatly increased energy requirements
for catch-up growth [18], which, given the other con-
straints of uremia, may be difficult to satisfy. When
the dietary intakes are expressed in relation to chro-
nological age they are inadequate. The dietary re-
cording was not supervised and the mean coefficient
of variation in five diet assessments per child was 15%
(range, 6 to 28%) but despite this the plasma glycine
still falls as energy intake rises, even when the mean
of several plasma glycine estimations over a six-
month period for each child is analyzed in relation to
the mean of the intakes over the same period. In fact,
the correlation between plasma glycine concentration
and fat and energy intake then becomes significant at
the 1% level and protein intake also becomes a signifi-
cant factor [19]. We do not know which method of
dietary assessment is most representative.
In contrast to our findings on valine and glycine,
Kopple and Swendseid [5] have shown that the
plasma valine/glycine ratio was affected both by
dietary protein and by uremia, being most reduced in
subjects on hemodialysis consuming a low-protein
diet. It is not clear whether the ratio was altered by
changes in glycine or valine concentration, or both,
and whether the diet had any effect on the plasma
valine concentration at all. Swendseid et al [20} have
shown that the plasma valine concentration falls rap-
idly in young healthy adults when their protein intake
is sharply reduced. We have found that in a group of
uremic children, despite considerable variation in
protein intake (0.5 to 4.8 g/kg of body wt/day), the
plasma valine concentration did not show related
variation, although it was reduced in the group as a
whole. It may be that, taking each child as his own
control, a further reduction in plasma valine concen-
tration might occur if protein intake is sharply re-
duced, but the distinct lack of correlation of valine
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with diet suggests that its alteration is due more to
effects of the uremic state on protein metabolism. The
plasma albumin concentration also did not correlate
with diet and possibly its relation to plasma valine
indicates that both reflect the nutritional state of the
individual whether there is protein deficiency for
metabolic or dietary reasons. The plasma glycine on
the other hand may be more responsive to alterations
in the actual dietary intake.
If it is accepted that the intakes of these children,
while not fulfilling the requirements for much catch-
up growth, are adequate according to body size, then
the changes in the amino acid concentrations we have
found may be metabolic in origin. Essential amino
acid losses in the dialysate are not greater than nones-
sential amino acid losses and are easily replaced by
the diet [17].
There is evidence that glucose [21] and lipid metab-
olism [22] are abnormal'in uremia, with peripheral
resistance to insulin and thus impaired utilization of
glucose with hyperinsulinemia. Either secondarily or
independently, lipid uptake appears to be reduced
[23] and lipolysis may also be reduced [24]. These
may interfere with the supply of energy substrate, and
amino acids may be diverted from protein production
to energy, a paradoxical finding in the face of hyper-
insulinemia which stimulates the cellular uptake of
amino acids. However, a similar metabolic state is
seen in sepsis accompanied by acute starvation [25].
In chronic protein wasting states, as in uremia, the
plasma concentrations of the branched-chain amino
acids are reduced [261. Preferential oxidation of the
branched-chain amino acids to CO2 occurs in muscle
[27] and we suggest that with impaired utilization of
conventional energy sources in uremia, oxidation of
the branched-chain amino acids occurs to provide
energy, leaving a surfeit of other nonessential amino
acids. The raised plasma alanine concentrations in
some patients may be an indication of its increased
peripheral release as essential amino acids are used
up for energy. Disordered lipid metabolism is in part
shown by high concentrations of plasma triglycerides
(TG) and we have found that as energy intakes in-
creased TG concentrations tended to fall [19]. The
mean plasma alanine concentration at the upper limit
of normal disguises how several patients had consid-
erably elevated concentrations (Fig. 2), which were
associated with elevated TG concentrations. How-
ever, diet had no effect on alanine concentration and
these abnormalities may be present for unrelated rea-
sons, although it seems appropriate to try and explain
them by a single hypothesis of altered energy metab-
olism.
The fall in plasma amino acid concentrations after
glucose in the present study is similar to that de-
scribed in healthy subjects [28]. It is insulin-con-
trolled and does not occur in insulin-dependent dia-
betes [29]. The fall in alanine concentration, which
we found, is not typically found in response to glu-
cose, or insulin, where no change or even an increase
may occur [28, 30, 31]. In three of the children its
concentration did rise after glucose. We have found
that those patients with the poorest glucose uptake
had the highest fasting alanine concentrations, with
the greatest reductions (to normal levels) after glu-
cose. Possibly those patients with the poorest glucose
tolerance were those who used up more essential
amino acids for energy. When augmented insulin se-
cretion in response to glucose occurred, there was a
resurgence of protein synthesis with a reduction in
the release of previously unusable nonessential amino
acids, including alanine.
Raised citrulline concentrations in uremia appear
to be a consequence of reduced extrahepatic utiliza-
tion, as its production in the liver is actually reduced
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and subsequent intrahepatic metabolism normal in
uremia [6]. Its direct relation to protein intake sug-
gests that as intake improves either its production
increases, or by some "toxic" effect its utilization is
further reduced.
Certain correlations between some biochemical
and other changes in uremia have been demonstrated
in this study and we have suggested that some of
these are causally related. It is true that our com-
parisons are of variations in a heterogenous group of
patients and without controlled variation of a single
parameter they must be interpreted cautiously. A
more precise study is needed, therefore, to determine
these individual aspects, and to determine whether a
single hypothesis of disturbed energy metabolism is
tenable.
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